by John A. Jenkins | Apr 9, 2025 | FDA, FOIA, Medical Devices, Pharmaceuticals
FOIAengine: Revolving Door Hits Pfizer on the Way Out The revolving door between the Food and Drug Administration and the pharmaceutical industry took another fast spin when Pfizer announced that Patrizia Cavazzoni would be returning to the company as its chief...
by John A. Jenkins | Jan 8, 2025 | FDA, FOIA, Pharmaceuticals
FOIAengine: How Lilly, Novo Nordisk, Others Use FOIA Welcome to 2025. At PoliScio Analytics, we logged 45,720 federal FOIA requests into our FOIAengine database during the past 12 months. But one subject, more than most others, dominated in hundreds of requests...
by John A. Jenkins | Dec 11, 2024 | FDA, FOIA, News Media, Politics
FOIAengine: HHS Designee Is Target After Calling FDA “Corrupt” Freedom of Information Act requests from the news media about Robert F. Kennedy Jr. hit the Food and Drug Administration almost immediately after President-elect Trump announced his choice of Kennedy to...
by John A. Jenkins | Nov 6, 2024 | FDA, FOIA
FOIAengine: Media Requests Signaled Issues for a “Party Drug” Going Mainstream With 153 clinical trials to assess whether the party drug known as Ecstasy can help patients suffering from Post Traumatic Stress Disorder, optimism was high earlier this summer among...
by John A. Jenkins | Oct 31, 2024 | FDA, FOIA, Law Firms, Litigation
FOIAengine: Hundreds of Requests About FDA’s Tobacco Regulation With cigarette makers battling for market dominance in a “smoke-free future,” legal and marketing battles are raging – and recent Freedom of Information Act requests may signal what’s coming next. Womble...
by Randy E. Miller | Oct 24, 2024 | FDA, FOIA, Law Firms, Litigation
FOIAengine: Questions from Siri & Glimstad Point to Possible Litigation Does radiation from cell phones and cell towers affect human health? There has long been controversy around this question, which the federal government has tried to put to rest by issuing...
